Study on the Effect of 40 Hz Non-Invasive Light Therapy System

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The ALZLIGHT STAGE III Study is a continuation of the ALZLIGHT Pilot - Study on Safety, Feasibility and Neural Activation of Non-Invasive Light Therapy System. As with the first two stages, this study will examine whether entrainment of 40 Hz neural oscillation by novel 40 Hz Invisible Spectral Flicker is a potential therapy for Alzheimer\'s Disease. In order to examine this, 62 patients with mild to moderate Alzheimer\'s Disease will be recruited. The patients will be exposed to the Non-Invasive Light Therapy System for 1 hour a day for 6 months. The effect will be measured by a combination of electroencephalography, cognitive testing, functional magnetic resonance imaging, magnetic resonance spectroscopy and actigraphy.
Epistemonikos ID: 381525ffda93576f77980561f292218738ba5ae3
First added on: May 10, 2024